Skip to the page content
Your donations
Passes our checks

Boston Biostatistics Research Fdn Inc

EIN 04-2999619 · Framingham, MA

Public records show a registered, tax-exempt organization in good standing.

LegitimacyPassesRegistration and standingFinancial healthStrong100 out of 100GovernanceWeak40 out of 100Impact evidenceDescribes programsHow well its results are evidenced

What it says it does

STATISTICAL MEDICAL RESEARCH

Income
$3.5 million
Spending
$1.8 million
Spent on programs
92%
Reserves
99.8 months of spending
Largest source of income
fees for its services, 65%
Employees
3
Highest pay
$288,000, pres/treas/c

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Financial health

Strong: 100 out of 100. Higher than 86% of charities in its peer group (science, $1m to $10m).

  • Reserves

    35 of 35

    Spendable reserves would cover 99.8 months of spending.

  • Debt

    20 of 20

    It owes 0% of what it owns.

  • Living within its means

    15 of 15

    Income exceeded spending by 50% of income.

  • Income trend

    15 of 15

    Income rose 222% on the year before.

  • Spending floor

    15 of 15

    92% of spending went to programs.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Governance

Weak: 40 out of 100. Higher than 4% of charities in its peer group (science, $1m to $10m).

  • Independent board

    0 of 25

    0 of 1 voting board members are independent.

  • Conflict of interest policy

    0 of 15

    Reports no written conflict of interest policy.

  • Whistleblower policy

    0 of 8

    Reports no written whistleblower policy.

  • Record keeping policy

    0 of 7

    Reports no written policy on keeping and destroying records.

  • Board minutes

    5 of 5

    Keeps minutes of board meetings.

  • Board sees the tax return

    10 of 10

    Gave the board a copy of this return before filing it.

  • Pay set independently

    0 of 5

    Reports no independent review process for its chief executive's pay.

  • Independent check of accounts

    15 of 15

    Its accounts were audited by an independent accountant.

  • No reported misuse

    10 of 10

    Reports no diversion of assets, excess benefits or loans to insiders.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Impact evidence

Describes programs. Its tax return describes what it does but we have found no measurable results in it.

Programs described in its return (1)
  1. $1.6 million spent. BOSTON BIOSTATISTICS RESEARCH FOUNDATIONS INC. PERFORMED DATA ANALYSES FOR MULTIPLE PUBLIC HEALTH STUDIES INVOLVING BREAST CANCER DIAGNOSIS USING OPTOACOUSTICS; HEAD AND NECK CANCER USING IMMUNOTHERAPY, COLORECTAL CANCER SCREENING USING A STOOL-BASED DNA TEST; PERIPHERAL BLOOD FLOW IMPROVEMENT USING A NOVEL STENT; WEIGHT LOSS FOLLOWING GASTRIC BALLOON INSERTION; AND KNEE OSTEOARTHRITIS FOLLOWING LUBRICANT INJECTION. THREE PAPERS ON COLORECTAL CANCER SCREENING, SUBACROMIAL BALLOON PLACEMENT, AND AN IMPROVED AUTONOMOUS AI SYSTEM FOR DIABETIC RETINAL DISEASE WERE PUBLISHED. FOUR ABSTRACTS WERE ACCEPTED FOR TALKS ON CANCER TREATMENT, CANCER DIAGNOSIS, DRY AMD, AND DIABETIC RETINOPATHY DETECTION. WE HELPED WRITE GRANT PROPOSALS FOR DENTAL IMAGING AND CATHETER COATING. WE CONTINUED TO REVIEW PUBLICATIONS FOR MEDICAL JOURNALS. WE CONDUCTED STATISTICAL RESEARCH IN STUDY DESIGN AND ANALYSIS METHODS WITH A NEW METHOD DEVELOPED TO IMPUTE MISSING DATA. WE DEVELOPED A NEW ALGORITHM TO IDENTIFY THE BEST POPULATION TO BE TREATED WITH A NEO-ADJUVANT IMMUNOTHERAPY. BOSTON BIOSTATISTICS RESEARCH FOUNDATIONS INC. PERFORMED DATA ANALYSES FOR MULTIPLE PUBLIC HEALTH STUDIES INVOLVING BREAST CANCER DIAGNOSIS USING OPTOACOUSTICS; HEAD AND NECK CANCER USING IMMUNOTHERAPY, COLORECTAL CANCER SCREENING USING A STOOL-BASED DNA TEST; PERIPHERAL BLOOD FLOW IMPROVEMENT USING A NOVEL STENT; WEIGHT LOSS FOLLOWING GASTRIC BALLOON INSERTION; AND KNEE OSTEOARTHRITIS FOLLOWING LUBRICANT INJECTION. THREE PAPERS ON COLORECTAL CANCER SCREENING, SUBACROMIAL BALLOON PLACEMENT, AND AN IMPROVED AUTONOMOUS AI SYSTEM FOR DIABETIC RETINAL DISEASE WERE PUBLISHED. FOUR ABSTRACTS WERE ACCEPTED FOR TALKS ON CANCER TREATMENT, CANCER DIAGNOSIS, DRY AMD, AND DIABETIC RETINOPATHY DETECTION. WE HELPED WRITE GRANT PROPOSALS FOR DENTAL IMAGING AND CATHETER COATING. WE CONTINUED TO REVIEW PUBLICATIONS FOR MEDICAL JOURNALS. WE CONDUCTED STATISTICAL RESEARCH IN STUDY DESIGN AND ANALYSIS METHODS WITH A NEW METHOD DEVELOPED TO IMPUTE MISSING DATA. WE DEVELOPED A NEW ALGORITHM TO IDENTIFY THE BEST POPULATION TO BE TREATED WITH A NEO-ADJUVANT IMMUNOTHERAPY.

Source: Form 990 for the year ending December 31, 2024, filed with the Internal Revenue Service. Rating method 2026.2. How we rate

Legitimacy checks

  1. Is it registered with the IRS? Passed.

    Listed in the IRS master file of tax-exempt organizations as a 501(c)(3) charitable organization.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  2. Has the IRS revoked its tax-exempt status? Passed.

    Not on the IRS automatic revocation list.

    Source: Automatic revocation of exemption list, Internal Revenue Service, file dated October 13, 2026.

  3. Are donations tax-deductible? Passed.

    On the IRS list of organizations eligible to receive tax-deductible contributions.

    Source: Publication 78 data: organizations eligible for tax-deductible contributions, Internal Revenue Service, file dated October 13, 2026.

  4. Is it keeping up with its IRS filings? Passed.

    Most recent return on file covers the year ending December 2024.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  5. How long has it been tax-exempt? Passed.

    Recognized by the IRS since September 1988.

    Source: Exempt Organizations Business Master File, Internal Revenue Service, file dated October 13, 2026.

  6. Is it in good standing with state regulators? Passed.

    Not on California's list of charities barred from soliciting. Other states are not yet checked.

    Source: May Not Operate or Solicit for Charitable Purposes list, California Attorney General, Registry of Charities and Fundraisers, file dated October 21, 2026.

Ratings and checks are our reading of public records, using the published method. They are not a statement about anyone's honesty. If you work for this organization, you can send corrections or results, confirm you want gifts through Veridonate, or ask to be removed from giving.